Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
One hundred febrile episodes in 89 neutropenic patients after cytotoxic chemotherapy were randomized to be treated with either ceftazidime or imipenem as initial monotherapy. The clinical characteristics of the two groups of patients were comparable. The response of the fever in patients who receive...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1990
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175977/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2201252/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.7.1336 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
